Product Development (PDSC)
The Product Development Science Committee (PDSC) recognizes the importance of identifying new biomedical interventions and integrating state-of-the-art methods and technologies into the research priority areas. Experts in the areas of antiretrovirals (ARV) for prevention, Multipurpose Prevention Treatments (MPT), and broadly neutralizing antibodies (bnAbs) collaborate in the protocol development and testing of novel products and delivery systems to prevent the acquisition and transmission of HIV and other sexually transmitted infections.
Co-Chairs
Colleen F. Kelley, MD, MPH
Emory University School of Medicine
Members
Linda-Gail Bekker
Linda-Gail BekkerSusan Buchbinder
Susan BuchbinderSufia Dadabhai
Sufia DadabhaiSharon Hillier
Sharon HillierKudzai Hlahla
Kudzai HlahlaSybil Hosek
Sybil HosekKenneth Mayer
Kenneth MayerErnest Moseki
Ernest MosekiAbubaker Saeed
Abubaker SaeedShobha Swaminathan
Shobha SwaminathanSupporting Staff
Mark Marzinke, HPTN LC SME
Paul Richardson, HPTN LC
Fei Gao, HPTN SDMC
Brett Hanscom, HPTN SDMC
Scott Rose, HPTN LOC
Elsie Talavera, HPTN Admin
Contact the Product Development Science Committee (PDSC) at pdsc@hptn.org.
See Our Other Science Committees:
Sexually Transmitted Infections Science Committee (STISC)